| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 665549 | 72463 | ESPINO ALBAR ARKOPHARMA cápsulas duras | ESPINO ALBAR ARKOPHARMA cápsulas duras , 48 cápsulas | 350 mg | 6 | 48 | 43 | 48 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72463/72463_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72463/72463_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2010-06-28 | 1 | 1 | 1 | 2010-06-28 | 2010-06-28 | 0 | 2011-04-25 | View Edit Delete | ||||||||||||
| 665550 | 72463 | ESPINO ALBAR ARKOPHARMA cápsulas duras | ESPINO ALBAR ARKOPHARMA cápsulas duras , 84 cápsulas | 350 mg | 6 | 84 | 43 | 84 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72463/72463_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72463/72463_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2010-06-28 | 1 | 1 | 1 | 2010-06-28 | 2010-06-28 | 0 | 2026-06-11 | View Edit Delete | ||||||||||||
| 665665 | 72529 | HARPAGOFITO ARKOPHARMA CÁPSULAS DURAS | HARPAGOFITO ARKOPHARMA CÁPSULAS DURAS , 168 cápsulas | 435 mg | 6 | 168 | 43 | 168 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72529/72529_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72529/72529_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 23799 | ARKOPHARMA LABORATORIOS S.A.U. | 2010-07-14 | 1 | 1 | 1 | 2010-07-14 | 2011-05-04 | 0 | 2018-12-04 | View Edit Delete | ||||||||||||
| 665919 | 61771 | DIPEPTIVEN 200 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DIPEPTIVEN 200 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 frasco de 100 ml | 200 mg/ml inyectable 100 ml | 6 | 1 | 48 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61771/61771_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61771/61771_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 1998-06-01 | 1 | 1 | 1 | 1998-06-01 | 1998-06-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665927 | 61771 | DIPEPTIVEN 200 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION | DIPEPTIVEN 200 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 frasco de 50 ml | 200 mg/ml inyectable 50 ml | 6 | 1 | 48 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61771/61771_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61771/61771_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1097 | FRESENIUS KABI ESPAÑA, S.A.U. | 1998-06-01 | 1 | 1 | 1 | 1998-06-01 | 1998-06-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665521 | 61791 | ACEOTO 3 MG/ML GOTAS ÓTICAS EN SOLUCIÓN | ACEOTO 3 MG/ML GOTAS ÓTICAS EN SOLUCIÓN , 1 frasco de 10 ml | 3 mg/ml | 6 | 10 | 26 | 1 frasco de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61791/61791_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61791/61791_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29563 | ZAMBON S.A.U. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 669887 | 57849 | FLUTOX 3,54 mg/ml JARABE | FLUTOX 3,54 mg/ml JARABE , 1 frasco de 200 ml | 3,54 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57849/57849_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57849/57849_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29563 | ZAMBON S.A.U. | 1988-12-01 | 1 | 1 | 1 | 1988-12-01 | 2001-01-17 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 671656 | 72582 | MASTICAL D 500 MG/800 UI COMPRIMIDOS MASTICABLES | MASTICAL D 500 MG/800 UI COMPRIMIDOS MASTICABLES, 30 comprimidos | 1.250 mg (500 mg Ca)/800 UI | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72582/72582_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72582/72582_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 2011-03-18 | 1 | 1 | 1 | 2011-03-18 | 2011-03-18 | 1 | 2011-12-20 | View Edit Delete | ||||||||||||
| 665939 | 10637001 | LEFLUNOMIDA MEDAC 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEFLUNOMIDA MEDAC 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 10 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10637001/10637001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10637001/10637001_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11137 | LABORATORIOS GEBRO PHARMA S.A. | 2011-02-15 | 1 | 1 | 1 | 2011-02-15 | 2011-02-15 | 1 | 2011-07-27 | View Edit Delete | ||||||||||||
| 665941 | 10637006 | LEFLUNOMIDA MEDAC 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEFLUNOMIDA MEDAC 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 20 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10637006/10637006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10637006/10637006_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 11137 | LABORATORIOS GEBRO PHARMA S.A. | 2011-02-15 | 1 | 1 | 1 | 2011-02-15 | 2011-02-15 | 1 | 2011-07-27 | View Edit Delete | ||||||||||||
| 665558 | 57273 | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE | IOPAMIRO 300 mg/ml SOLUCION INYECTABLE , 1 frasco de 500 ml | 300 mg/ml | 6 | 1 | 48 | 1 frasco de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57273/57273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57273/57273_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 2010-06-24 | 1 | 2013-06-24 | View Edit Delete | ||||||||||||
| 665559 | 57272 | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE | IOPAMIRO 370 mg/ml SOLUCION INYECTABLE , 1 frasco de 500 ml | 370 mg/ml | 6 | 1 | 48 | 1 frasco de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57272/57272_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57272/57272_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 9505 | LABORATORIOS FARMACEUTICOS ROVI S.A. | 1987-09-01 | 1 | 1 | 1 | 1987-09-01 | 2010-06-24 | 1 | 2013-06-28 | View Edit Delete | ||||||||||||
| 665828 | 63212 | AMOXICILINA/ACIDO CLAVULANICO VIATRIS 125 MG/5 MG +31,25 MG/5 ML POLVO PARA SUSPENSION ORAL EFG | AMOXICILINA/ACIDO CLAVULANICO VIATRIS 125 MG/5 MG +31,25 MG/5 ML POLVO PARA SUSPENSION ORAL EFG, 1 frasco de 120 ml | 125 mg/5 ml + 31,25 mg/5 ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63212/63212_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63212/63212_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38105 | VIATRIS PHARMACEUTICALS S.L. | 2000-07-10 | 1 | 1 | 1 | 2000-07-10 | 2000-12-20 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 666107 | 59166 | DALSY 20 mg/ml SUSPENSION ORAL | DALSY 20 mg/ml SUSPENSION ORAL , 1 frasco de 150 ml | 20 mg/ml | 6 | 200 | 26 | 1 frasco de 150 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59166/59166_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59166/59166_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L. | 1991-12-01 | 1 | 1 | 1 | 1991-12-01 | 1997-10-01 | 1 | 2012-01-09 | 880419, 684217 | View Edit Delete | |||||||||||
| 665804 | 09599018 | RIVASTIGMINA SANDOZ 2 mg/ml SOLUCION ORAL EFG | RIVASTIGMINA SANDOZ 2 mg/ml SOLUCION ORAL EFG, 1 frasco de 120 ml | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09599018/09599018_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09599018/09599018_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2010-05-10 | 1 | 1 | 1 | 2010-05-10 | 2010-05-10 | 1 | 2013-01-30 | View Edit Delete | ||||||||||||
| 669362 | 72143 | ONY-TEC 80 mg/g BARNIZ DE UÑAS MEDICAMENTOSO | ONY-TEC 80 mg/g BARNIZ DE UÑAS MEDICAMENTOSO , 1 frasco de 6,6 ml | 80 mg/g | 6 | 6,6 | 26 | 1 frasco de 6,6 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72143/72143_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72143/72143_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88187 | ALMIRALL S.A. | 2010-07-08 | 1 | 1 | 1 | 2010-07-08 | 2010-07-08 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 667709 | 61728 | ENTOCORD 3 mg CAPSULAS DE LIBERACION MODIFICADA | ENTOCORD 3 mg CAPSULAS DE LIBERACION MODIFICADA, 50 cápsulas | 3 mg | 6 | 50 | 43 | 50 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61728/61728_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61728/61728_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 20368 | TILLOTTS PHARMA SPAIN S.L.U. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 665721 | 72514 | GALANTAMINA NORMON 4 mg/ml SOLUCION ORAL EFG | GALANTAMINA NORMON 4 mg/ml SOLUCION ORAL EFG, 1 frasco de 100 ml (PET) | 4 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml (PET) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72514/72514_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72514/72514_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2010-07-13 | 1 | 1 | 1 | 2010-07-13 | 2010-07-13 | 1 | 2012-02-28 | View Edit Delete | ||||||||||||
| 665747 | 02205003 | LUMIGAN 0,1 mg/ml COLIRIO EN SOLUCION | LUMIGAN 0,1 mg/ml COLIRIO EN SOLUCION, 1 frasco de 3 ml | 0,1 mg/ml | 6 | 3 | 26 | 1 frasco de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/02205003/02205003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/02205003/02205003_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2010-02-12 | 1 | 1 | 1 | 2010-02-12 | 2010-02-12 | 1 | 2011-11-21 | View Edit Delete | ||||||||||||
| 665749 | 96016005 | NORVIR 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | NORVIR 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 100 mg | 6 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/96016005/96016005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/96016005/96016005_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 41086 | ABBVIE SPAIN, S.L.U. | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2012-01-09 | View Edit Delete |
Page 240 of 1036, showing 20 records out of 20709 total, starting on record 4781, ending on 4800